All Stories

  1. PCSK9 Inhibition-Based Therapeutic Approaches: An Immunotherapy Perspective
  2. New trends in the pharmacological intervention of PPARs in obesity: Role of natural and synthetic compounds_
  3. Sirtuin-6 inhibits cardiac fibroblasts differentiation into myofibroblasts via inactivation of nuclear factor κB signaling
  4. Cryptotanshinone, an orally bioactive herbal compound from Danshen, attenuates atherosclerosis in apolipoprotein E-deficient mice: role of lectin-like oxidized LDL receptor-1 (LOX-1)
  5. Essential roles of Gab1 tyrosine phosphorylation in growth factor-mediated signaling and angiogenesis
  6. Osthole, a Natural Coumarin Improves Cognitive Impairments and BBB Dysfunction After Transient Global Brain Ischemia in C57 BL/6J Mice: Involvement of Nrf2 Pathway
  7. Tumor suppressor gene ING3 induces cardiomyocyte hypertrophy via inhibition of AMPK and activation of p38 MAPK signaling
  8. Cryptotanshinone Attenuates Cardiac Fibrosis via Downregulation of COX-2, NOX-2, and NOX-4
  9. Effectiveness of combination therapy of atorvastatin and non lipid-modifying tanshinone IIA from Danshen in a mouse model of atherosclerosis
  10. Targeting hydrogen sulfide as a promising therapeutic strategy for atherosclerosis
  11. Sirolimus Decreases Circulating Lymphangioleiomyomatosis Cells in Patients With Lymphangioleiomyomatosis
  12. Transforming growth factor-β signalling: Role and consequences of Smad linker region phosphorylation
  13. HDL cholesterol in cardiovascular diseases: The good, the bad, and the ugly?
  14. Poly(ADP-ribose) Polymerase 1 (PARP1) in Atherosclerosis: From Molecular Mechanisms to Therapeutic Implications
  15. Fenofibrate ameliorates cardiac hypertrophy by activation of peroxisome proliferator-activated receptor-α partly via preventing p65-NFκB binding to NFATc4
  16. Rock the Rock of Atherosclerosis
  17. Tanshinone II-A: new perspectives for old remedies
  18. LOX-1 in atherosclerosis: biological functions and pharmacological modifiers
  19. Roles of transcriptional corepressor RIP140 and coactivator PGC-1α in energy state of chronically infarcted rat hearts and mitochondrial function of cardiomyocytes
  20. Tanshinone II-A inhibits oxidized LDL-induced LOX-1 expression in macrophages by reducing intracellular superoxide radical generation and NF-κB activation
  21. Corrigendum to: Cardiovascular actions and therapeutic potential of tanshinone IIA [Atherosclerosis 220 (2012) 3–10]
  22. PPARα activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4
  23. Cardiovascular actions and therapeutic potential of tanshinone IIA
  24. Sphingosine Kinase-1 Pathway Mediates High Glucose-Induced Fibronectin Expression in Glomerular Mesangial Cells
  25. Tanshinone II-A attenuates and stabilizes atherosclerotic plaques in Apolipoprotein-E knockout mice fed a high cholesterol diet
  26. Osthole, a natural coumarin, improves neurobehavioral functions and reduces infarct volume and matrix metalloproteinase-9 activity after transient focal cerebral ischemia in rats
  27. Simultaneous determination of sphingosine and sphingosine 1-phosphate in biological samples by liquid chromatography–tandem mass spectrometry
  28. Berberine attenuates lipopolysaccharide-induced extracelluar matrix accumulation and inflammation in rat mesangial cells: Involvement of NF-κB signaling pathway
  29. Evaluation of foam cell formation in cultured macrophages: an improved method with Oil Red O staining and DiI-oxLDL uptake
  30. Berberine ameliorates renal injury in diabetic C57BL/6 mice: Involvement of suppression of SphK–S1P signaling pathway
  31. Determination of sphingosine kinase activity in biological samples by liquid chromatography-tandem mass spectrometry
  32. Regulated expression of endothelial lipase in atherosclerosis
  33. Development of an optimized protocol for primary culture of smooth muscle cells from rat thoracic aortas